The most common ADHD medications fall into two broad categories: stimulants and non-stimulants. Stimulants are the first-line treatment for most people and work by increasing levels of certain brain chemicals that help with focus and impulse control. Non-stimulants are typically prescribed when stimulants cause intolerable side effects or aren’t a good fit due to other health conditions.
Stimulant Medications
Stimulants are built around one of two active ingredients: methylphenidate or amphetamine. Both increase the availability of signaling chemicals in the brain that regulate attention, motivation, and self-control. They differ somewhat in how they work at the molecular level, and many people respond better to one than the other, which is why doctors often try both before settling on a long-term option.
Methylphenidate-Based Options
Methylphenidate is the active ingredient in Ritalin, Concerta, Focalin, Daytrana (a skin patch), and several generic formulations. The short-acting versions (like Ritalin) last about three to four hours and are taken two or three times a day. Long-acting versions cover most of the day with a single dose.
Concerta uses a particularly interesting delivery system. The tablet has an outer coating that dissolves quickly for an initial dose, then an internal chamber that absorbs water and slowly pushes medication out through a tiny laser-drilled hole over the next several hours. This creates a rising blood level throughout the day, which is designed to match the pattern of when people typically need the most focus. Concerta is usually started at 18 mg daily, with a maximum of 54 mg for children under 13 and 72 mg for teens and adults.
Amphetamine-Based Options
Amphetamine-based medications include Adderall (mixed amphetamine salts), Adderall XR (the extended-release version), Vyvanse, and Dexedrine. Adderall XR is commonly started at 5 to 10 mg daily, with a maximum of 30 mg. Vyvanse typically starts at 20 to 30 mg for children six and older, with a ceiling of 70 mg.
Vyvanse stands out because it’s a prodrug, meaning the capsule contains an inactive compound that your body has to convert into the active medication during digestion. This built-in activation step creates a smoother onset and makes the drug harder to misuse, since taking more doesn’t produce a faster effect. It also tends to produce a more gradual wind-down at the end of the day compared to some other long-acting formulations.
Non-Stimulant Medications
The FDA has approved four non-stimulant medications for ADHD: atomoxetine (Strattera), guanfacine (Intuniv), clonidine (Kapvay), and viloxazine (Qelbree). These work through different brain pathways than stimulants and carry no risk of the kind of dependence associated with controlled substances.
Atomoxetine (Strattera) blocks the reabsorption of norepinephrine, a brain chemical involved in alertness and attention. Unlike stimulants, which can start working within an hour, atomoxetine builds up gradually and often takes several weeks to reach full effectiveness. It’s approved for both children and adults.
Guanfacine (Intuniv) and clonidine (Kapvay) were originally developed to treat high blood pressure and later found to help with ADHD symptoms, particularly hyperactivity and impulsivity. They can cause drowsiness, especially early on, which is why they’re sometimes dosed at bedtime. Some providers prescribe them alongside a stimulant to address symptoms the stimulant doesn’t fully cover.
Viloxazine (Qelbree) is the newest option, approved for children over six and adults. It works by increasing norepinephrine activity in the brain. Clinical trials involving over 1,100 children and 374 adults showed it reduced symptoms of inattention, hyperactivity, and impulsivity compared to placebo, though the improvement was modest. It’s generally considered when other options haven’t worked well or aren’t appropriate.
Side Effects of Stimulants
Appetite suppression is the most common side effect of stimulant medications, affecting roughly 80% of people who take them. This tends to be strongest during the hours the medication is active, which is why many people find they’re not hungry at lunch but ravenous in the evening. For children, parents often shift the largest meal to breakfast or a late dinner to keep calorie intake on track. Growth monitoring is standard practice for kids on long-term stimulant therapy.
Sleep difficulty is the other hallmark side effect. Stimulants can make it harder to fall asleep, reduce sleep quality, and shorten total sleep time. Taking the medication earlier in the day or switching to a formulation that wears off sooner can help. Some people also experience increased heart rate, dry mouth, headaches, or irritability as the medication wears off (sometimes called a “rebound” effect).
Side Effects of Non-Stimulants
Non-stimulants have a different side effect profile. Atomoxetine commonly causes nausea, fatigue, and decreased appetite, though appetite effects are generally milder than with stimulants. Guanfacine and clonidine can cause drowsiness, low blood pressure, and dizziness, particularly during the first few weeks or when adjusting the dose. Viloxazine’s most frequent side effects include sleepiness, decreased appetite, and nausea.
One advantage of non-stimulants is that they don’t typically cause the sleep problems associated with stimulants. In fact, guanfacine and clonidine can actually help with sleep, which makes them appealing for people whose ADHD coexists with insomnia.
Short-Acting vs. Long-Acting Formulations
Most ADHD medications come in both short-acting and long-acting versions. Short-acting formulations last three to six hours and give you more control over timing, since you can take a dose only when you need coverage. The tradeoff is that you may need multiple doses per day, and there can be noticeable peaks and valleys in symptom control.
Long-acting formulations are designed to last 8 to 12 hours with a single morning dose. They use various technologies to release medication gradually: beaded capsules that dissolve at different rates, osmotic pumps, or prodrug conversion. For school-age children, long-acting medications eliminate the need to take a dose during the school day, which simplifies things considerably. For adults, a single morning dose can cover most of the workday.
Heart Health and Monitoring
All ADHD medications, both stimulant and non-stimulant, can affect heart rate and blood pressure. For most healthy people this effect is minor, but it requires baseline screening and ongoing monitoring. The American Academy of Pediatrics recommends checking blood pressure and heart rate within one to three months of starting medication, then every 6 to 12 months at follow-up visits, with more frequent checks when adjusting doses of guanfacine or clonidine.
Stimulant medications carry specific warnings for people with structural heart abnormalities, cardiomyopathy, heart rhythm disorders, or moderate to severe high blood pressure. If you have any known heart condition, your provider will typically want a cardiology evaluation before prescribing a stimulant. A standard pre-treatment screening involves a personal and family history focused on fainting, unexplained chest pain, and sudden cardiac death in close relatives.
You should also know that ADHD medications, both stimulants and non-stimulants, should not be combined with a class of older antidepressants called MAO inhibitors due to the risk of dangerous blood pressure spikes. This combination is rare today, but it’s worth mentioning if you take any psychiatric medication.
How Medications Are Chosen
There’s no blood test or brain scan that predicts which ADHD medication will work best for a given person. Treatment typically starts with a low dose of a stimulant, since stimulants have the strongest evidence and fastest onset. If the first stimulant tried doesn’t work well or causes problematic side effects, the usual next step is to try the other stimulant class (switching from methylphenidate to amphetamine or vice versa). If neither stimulant is a good fit, non-stimulants are the next tier.
The process of finding the right medication and dose is often called titration. It involves starting low, increasing gradually, and checking in regularly to assess both symptom improvement and side effects. This can take several weeks to a few months, and it’s normal to try more than one medication before landing on the best option. Response rates to any single ADHD medication hover around 70%, but when both stimulant classes are tried, the combined response rate climbs significantly higher.